Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03254953 · ClinicalTrials.gov registry record · NA

GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
105
Enrollment target

NCT03254953 is a NA study that has completed, run by Duke University. The registered enrollment target is 105 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03254953, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
105 participants
Enrollment target

Study Summary

This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email. The investigators hypothesize that the group that delays diet tracking and receives additional intervention components (weekly personalized feedback, skills training, and action plans) will have greater weight loss at the end of the 12-week intervention and at 6-month followup, compared to (a) an intervention group that simultaneously tracks weight and diet for all 12 weeks and receives the same additional components, and (b) a control group that tracks only diet.

Interventions

  • BEHAVIORAL self-monitoring of body weight
  • BEHAVIORAL self-monitoring of diet
  • BEHAVIORAL weekly personalized feedback + lessons + action plans

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2017-04-19
Est. Completion 2018-03-02
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03254953

The ClinicalTrials.gov registry entry for NCT03254953 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which self-monitoring of body weight is the first listed.

NCT03254953 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03254953 about?

NCT03254953 is a clinical study titled "GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss". This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email. The investigators hypothesize that the group that delays diet tracking and r...

What is the current status of trial NCT03254953?

This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2017-04-19. Estimated completion is 2018-03-02.

What interventions are being tested in trial NCT03254953?

The interventions under investigation include: self-monitoring of body weight (BEHAVIORAL), self-monitoring of diet (BEHAVIORAL), weekly personalized feedback + lessons + action plans (BEHAVIORAL).

Who is sponsoring clinical trial NCT03254953?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.